Dermatology · Minneapolis, MN
NPI
1417188939
Since 2009
Specialty
Dermatology
Code 207N00000X
Group practices
6
Medicare group memberships
Hospitals
2
Hospital affiliations
909 Fulton St SE, Dept of Dermatology, Phillips Wangensteen Building
Minneapolis, MN, 55455
Phone (612) 672-7422
Groups this clinician bills Medicare through
Medicare paid, 2024
$6,157
116 services
Medicare patients, 2024
33
Average age 44
Drug cost, 2024
$2.8M
528 prescriptions
Company payments, 2025
$1,300
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Noah I Goldfarb was code 99214 (office e&m - established), 25 times for 19 patients. In total Noah I Goldfarb billed 116 services in 18 codes, and Medicare paid $6,157.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-07-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 25 | 19 | $97.24 | $2,431 |
By year: 2022 $6,933 for 138 services; 2023 $4,687 for 76 services; 2024 $6,157 for 116 services.
Medicare prescription drug claims, 2024
In 2024, the drug Noah I Goldfarb prescribed most often to Medicare patients was Cosentyx Sensoready (2 Pens) (Secukinumab), with 44 prescriptions and refills. In total Noah I Goldfarb wrote 528 Medicare prescriptions that cost $2.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Cosentyx Sensoready (2 Pens) Secukinumab | 44 | 44 | Under 11 | $585K |
| Ertapenem Ertapenem Sodium | 36 | 36 | Under 11 | $24K |
| Cosentyx Unoready Pen Secukinumab | 33 | 33 | Under 11 | $572K |
| Humira(Cf) Pen Adalimumab | 29 | 33 | Under 11 | $677K |
| Doxycycline Monohydrate Generic | 25 | 45 | Under 11 | $1,501 |
| Fluconazole Generic | 20 | 22 | Under 11 | $80.63 |
| Clobetasol Propionate Generic | 19 | 19 | 11 | $2,182 |
| Clindamycin Hcl Generic | 16 | 20 | Under 11 | $570 |
| Gabapentin Generic | 15 | 27 | Under 11 | $629 |
| Triamcinolone Acetonide Generic | 15 | 19 | Under 11 | $347 |
| Ketoconazole Generic | 15 | 15 | Under 11 | $380 |
| Finasteride Generic | 13 | 15 | Under 11 | $115 |
| Doxycycline Hyclate Generic | 13 | 20 | Under 11 | $471 |
| Lidocaine Generic | 13 | 13 | Under 11 | $272 |
| Stelara Ustekinumab | 13 | 19 | Under 11 | $368K |
Brand drugs: 199 claims; generic drugs: 329 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Noah I Goldfarb $1,300 ($1,300 in general payments such as food, travel and fees) from 2 companies. The largest payer was UCB, Inc. with $1,300.
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. UCB.BR | 1 | $1,300 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.